Shares

11 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2023

Nov 14, 2023

BUY
$8.25 - $11.35 $249,612 - $343,405
30,256 New
30,256 $291,000
Q1 2023

May 11, 2023

SELL
$10.37 - $12.56 $2.57 Million - $3.11 Million
-247,764 Reduced 71.56%
98,445 $1.04 Million
Q4 2022

Feb 10, 2023

SELL
$9.9 - $12.43 $1.54 Million - $1.93 Million
-155,368 Reduced 30.98%
346,209 $4.29 Million
Q3 2022

Nov 10, 2022

BUY
$10.14 - $12.38 $4.83 Million - $5.9 Million
476,201 Added 1876.58%
501,577 $5.2 Million
Q2 2022

Aug 11, 2022

SELL
$11.05 - $12.72 $106,278 - $122,340
-9,618 Reduced 27.48%
25,376 $293,000
Q1 2022

May 16, 2022

SELL
$10.61 - $12.88 $830,126 - $1.01 Million
-78,240 Reduced 69.1%
34,994 $451,000
Q4 2021

Feb 14, 2022

SELL
$10.86 - $13.95 $769,322 - $988,218
-70,840 Reduced 38.48%
113,234 $1.32 Million
Q2 2021

Aug 13, 2021

BUY
$10.16 - $13.11 $874,054 - $1.13 Million
86,029 Added 87.74%
184,074 $2.37 Million
Q1 2021

May 17, 2021

SELL
$9.04 - $11.86 $120,123 - $157,595
-13,288 Reduced 11.94%
98,045 $1.1 Million
Q4 2020

Feb 16, 2021

BUY
$9.05 - $12.2 $31,874 - $42,968
3,522 Added 3.27%
111,333 $1.27 Million
Q3 2020

Nov 13, 2020

BUY
$8.99 - $10.74 $969,220 - $1.16 Million
107,811 New
107,811 $1 Million

Others Institutions Holding IRWD

About IRONWOOD PHARMACEUTICALS INC


  • Ticker IRWD
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 153,231,008
  • Market Cap $682M
  • Description
  • Ironwood Pharmaceuticals, Inc., a healthcare company, focuses on the development and commercialization of gastrointestinal (GI) products. It markets linaclotide, a guanylate cyclase type-C agonist for the treatment of adults suffering from irritable bowel syndrome with constipation (IBS-C) or chronic idiopathic constipation (CIC) under the LINZE...
More about IRWD
Track This Portfolio

Track Schroder Investment Management Group Portfolio

Follow Schroder Investment Management Group and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Schroder Investment Management Group, based on Form 13F filings with the SEC.

News

Stay updated on Schroder Investment Management Group with notifications on news.